Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

The Glycemic Gap and 90-Day Mortality in Community-acquired Pneumonia: A Prospective Cohort Study

Research output: Contribution to journalJournal articleResearchpeer-review

  1. New Tobacco Products Do Not Protect Public Health

    Research output: Contribution to journalReviewResearchpeer-review

  2. Multiple Breath Washout for Diagnosing Asthma and Persistent Wheeze in Young Children

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Pneumonia risk with inhaled fluticasone furoate and vilanterol compared with vilanterol alone in patients with COPD

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Lower leptin/adiponectin ratio and risk of rapid lung function decline in chronic obstructive pulmonary disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Poor concordance between liver stiffness and non-invasive fibrosis scores in HIV infection without viral hepatitis

    Research output: Contribution to journalShort surveyResearchpeer-review

  2. Response to letter of concern regarding »Reduction in COVID-19 infection using surgical facial masks outside the healthcare system«

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Remdesivir for the Treatment of Covid-19 - Final Report

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Changes in Lyme neuroborreliosis incidence in Denmark, 1996 to 2015

    Research output: Contribution to journalJournal articleResearchpeer-review

  • German Community-Acquired Pneumonia Competence Network (CAPNETZ)
View graph of relations

Rationale: Hyperglycemia is associated with mortality in patients with community-acquired pneumonia (CAP), and hyperglycemia may be a biomarker of severity. However, hyperglycemia has a major disadvantage because the association is diminished in patients with diabetes mellitus (DM). This hampers the use of hyperglycemia as a biomarker. Accounting for habitual glucose levels could overcome this disadvantage.Objectives: We hypothesized that the glycemic gap (the difference between plasma glucose and the estimated average glucose) may be associated with mortality irrespective of DM.Methods: Among 1,933 adults with CAP included in a prospective multicenter cohort, we investigated the association between the glycemic gap and 90-day mortality. Hemoglobin A1c was used to estimate the average glucose. The association was assessed with Cox proportional hazard models after adjustment for age, sex, CURB-65 (Confusion, urea >7 mmol/L, respiratory rate ≥30 breaths/minute, systolic blood pressure <90 mmHg or diastolic blood pressure ≤60 mmHg and age ≥65 years), and comorbidities. In the prespecified analysis the absolute and relative glycemic gaps were used as a continuous variable. In a post hoc analysis, the absolute and relative glycemic gaps were used as a categorical variable grouped according to quartiles.Results: In the post hoc analysis, patients with the lowest (negative) and highest (positive) absolute glycemic gap quartiles had increased risk of 90-day mortality (hazard ratio, 2.6; 95% confidence interval, 1.02-6.65; and hazard ratio, 2.5; 95% confidence interval, 1.01-6.06, respectively). A similar association was found for the relative glycemic gap. The associations were independent of age, CURB-65 score, sex, or number of comorbidities and not modified by DM.Conclusions: Patients with the highest and lowest glycemic gap may have an increased risk of 90-day mortality, and the association was not modified by DM. These associations were found in an exploratory post hoc analysis and should be validated in other populations before further conclusions can be made.

Original languageEnglish
JournalAnnals of the American Thoracic Society
Volume16
Issue number12
Pages (from-to)1518-1526
Number of pages9
ISSN2325-6621
DOIs
Publication statusPublished - Dec 2019

    Research areas

  • biomarker, community-acquired pneumonia, mortality, prognosis

ID: 57846269